Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
ProMIS Neurosciences Inc
PMN
Healthcare
Biotechnology
ProMIS Neurosciences Inc. is a development stage biotechnology company. The Company is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA), an alpha-synucleinopathy. Its proprietary target discovery engine...
applies a thermodynamic, computational discovery platform - ProMIS and Collective Coordinates - to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Using this approach, the Company is developing novel antibody therapeutics for AD, ALS and MSA. Its product portfolio includes PMN310 / Amyloid-beta, PMN267 / TDP-43, and PMN442 / Alpha-synuclein. The Company plans to investigate additional synucleinopathies, including Parkinson's disease (PD) and dementia with Lewy bodies (DLB). Its wholly owned subsidiary is ProMIS Neurosciences (US) Inc.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:PMN)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jan 22, 2024 7:00am
New Press Release - ProMIS Neurosciences Achieves Milestone in Development of Therapeutic Alpha-Synuclein Vaccine
Lead vaccine candidate selected for advancement against synucleinopathies including Multiple System Atrophy, Parkinson’s disease and Dementia with Lewy bodies CAMBRIDGE, Massachusetts and TORONTO, Ontario, Jan. 22, 2024 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a biotechnology...
read article.
(107)
•••
M101
X
View Profile
View Bullboard History
Comment by
M101
on Jan 19, 2024 5:37pm
RE:overdone
Comfortable is tested, QED.
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development
posted May 02, 2024 9:00am by
Saturn Oil & Gas Inc.
-
|
Saturn has followed up its success in previous years drilling in Southeast Saskatchewan to enhance its IP30 initial production rates and overall return on invested capital. Saturn has recently finished drilling one gross (1.0 net) Open Hole Multi-Lateral ("OHML") well in the Viewfield area of Southeast Saskatchewan with eight horizontal legs of up to two miles each ...read more
(107)
•••
M101
X
View Profile
View Bullboard History
Post by
M101
on Jan 18, 2024 8:37pm
overdone
There's an 80 cent fibonacci on a run of 2.10, can we crawl back up to 2.25?
(107)
•••
M101
X
View Profile
View Bullboard History
Comment by
M101
on Jan 18, 2024 3:46pm
RE:RE:RE:RE:RE:Comfortably above the $2 NASDAQ delist line
I assume anyone with the influence to hold a significant naked short would equally have the influence to cover it with the placement. It's only illegal if you get caught and can't afford
...more
(13)
•••
garygp
X
View Profile
View Bullboard History
Comment by
garygp
on Jan 18, 2024 2:33pm
RE:RE:RE:RE:Comfortably above the $2 NASDAQ delist line
Once this took off a week or two ago, the group that naked shorted this last July got nervous and thought it best to cover that short. That would be prudent imo as there was a ton of stock
...more
(107)
•••
M101
X
View Profile
View Bullboard History
Comment by
M101
on Jan 18, 2024 1:02pm
RE:RE:RE:Comfortably above the $2 NASDAQ delist line
Looks like we'll soon test "comfortable". The Boston group decided to do the dirty work just under $2 so presumably that's within shooting distance of whatever they need to
...more
(39)
•••
BottomBroker
X
View Profile
View Bullboard History
Comment by
BottomBroker
on Jan 17, 2024 2:57pm
RE:RE:Comfortably above the $2 NASDAQ delist line
Ha. I like to keep things simple.
(107)
•••
M101
X
View Profile
View Bullboard History
Comment by
M101
on Jan 17, 2024 11:01am
RE:Comfortably above the $2 NASDAQ delist line
this may be too super-analytical, but ya
(39)
•••
BottomBroker
X
View Profile
View Bullboard History
Post by
BottomBroker
on Jan 17, 2024 9:56am
Comfortably above the $2 NASDAQ delist line
Doubt we'll move much from here for a while.
(107)
•••
M101
X
View Profile
View Bullboard History
Comment by
M101
on Jan 15, 2024 11:25am
RE:RE:CEO experiments
let it ride? so, how about those canucks
(97)
•••
G1945V
X
View Profile
View Bullboard History
Comment by
G1945V
on Jan 14, 2024 3:08pm
RE:CEO experiments
Every stock gets its turn at the bat. This hopefully is our time to hit it out of the park. Is there still the need to super-analyze PMN to no avail? We've done enough of that already! Let's
...more
(107)
•••
M101
X
View Profile
View Bullboard History
Post by
M101
on Jan 13, 2024 8:35pm
CEO experiments
The upside of our last CEO experiment is getting an unambiguous result with share price. So, if the same people pick another head with similar talents, we'll know what to expect. The market
...more
(107)
•••
M101
X
View Profile
View Bullboard History
Comment by
M101
on Jan 12, 2024 4:26pm
RE:RE:RE:RE:What’s Happening?
I doubt Cashman ever wanted the role. Martin Tolar seems to have that sort of role at Alzheon and it sometimes appears like a one man show. https://alzheon.com/investment-reports-article
...more
(30)
•••
bball67
X
View Profile
View Bullboard History
Comment by
bball67
on Jan 12, 2024 3:44pm
RE:RE:RE:What’s Happening?
I want to say one more thing which is my opinion. Gail seemed like a very good scientist. I was on two calls and she knew the science. She seemed like a nice person. You need someone to be enthused
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Significant New Silver Discoveries in the Famous Keno Hill District in the Yukon
This Gambling Tech Stock is Future-Proofing the World’s Casinos and has No Direct Competition
Silvercorp to Acquire Adventus, Creating a Geographically Diversified Mining Company
Revolutionary Tech Company Announces Fourth Quarter and Full Year 2023 Results
Drill Permit Approval Received for New Mexico Lithium Project
This profitable gold stock is on its way up
Mullen Group Ltd. Reports 2024 First Quarter Financial Results